Gladius Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,421
| Closed | -$22.4K | – | 346 |
|
|
2023
Q3 | $22.4K | Buy |
1,421
+107
| +8% | +$1.69K | ﹤0.01% | 244 |
|
|
2023
Q2 | $25.5K | Buy |
1,314
+262
| +25% | +$5.09K | ﹤0.01% | 194 |
|
|
2023
Q1 | $29.8K | Sell |
1,052
-2
| -0.2% | -$57 | ﹤0.01% | 203 |
|
|
2022
Q4 | $30.8K | Sell |
1,054
-73
| -6% | -$2.13K | ﹤0.01% | 249 |
|
|
2022
Q3 | $30K | Buy |
+1,127
| New | +$30K | ﹤0.01% | 252 |
|